Pityriasis rosea-like drug eruption secondary to deucravacitinib

JAAD Case Rep. 2024 Sep 1:53:63-65. doi: 10.1016/j.jdcr.2024.08.019. eCollection 2024 Nov.

Authors

Nisal Punchihewa^{1

2}, Senhong Lee^{1

3}, Chin-Guan Tan⁴, Peter Foley^{1

2

5}

Affiliations

¹ Skin Health Institute, Carlton, Victoria, Australia.
² The University of Melbourne, Parkville, Victoria, Australia.
³ Department of Dermatology, Monash Health, Victoria, Australia.
⁴ Department of Anatomical Pathology, Melbourne Pathology, Collingwood, Victoria, Australia.
⁵ Department of Dermatology, St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia.

No abstract available

Keywords: cutaneous adverse reaction; deucravacitinib; drug rash; medical dermatology; pityriasis rosea.

Publication types

Case Reports